Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.22 is 12% above its 5-year average of 7.35, around the middle of its 5-year range (3.06–14.95).
As of the fiscal period ended Tuesday, June 30, 2026. 75.90% above its 12-month average of 4.67.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.22.
QUICK RATIO (ACID-TEST)
8.22
QUICK RATIO (ACID-TEST) AVG TTM
4.67
QUICK RATIO (ACID-TEST) AVG 3Y
5.91
QUICK RATIO (ACID-TEST) AVG 5Y
7.35
QUICK RATIO (ACID-TEST) AVG 10Y
8.58
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.90%
CURRENT VS 3Y AVG
+39.06%
CURRENT VS 5Y AVG
+11.78%
CURRENT VS 10Y AVG
-4.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 691 covered companies
CURRENT VS SECTOR MEDIAN
+167.68%
vs the sector median at left
Market Cap
$240.98M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.13
3Y Avg
1.14
5Y Avg
1.18
Market Cap
$240.97M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
Market Cap
$242.35M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$243.62M
Quick Ratio (Acid-Test)
2.69
TTM Avg
2.01
3Y Avg
1.61
5Y Avg
1.29
Market Cap
$237.69M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.81
3Y Avg
0.76
5Y Avg
0.71
Market Cap
$237.38M
Quick Ratio (Acid-Test)
17.19
TTM Avg
13.55
3Y Avg
8.08
5Y Avg
8.08
Market Cap
$246.67M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$235.50M
Quick Ratio (Acid-Test)
2.96
TTM Avg
4.42
3Y Avg
4.46
5Y Avg
4.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $241.56M | 8.22 | 4.67 | 5.91 | 7.35 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | 1.35 | 1.13 | 1.14 | 1.18 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | 4.70 | 7.13 | 7.51 | 5.59 |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | 0.10 | 1.46 | 1.56 | 2.73 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | 2.69 | 2.01 | 1.61 | 1.29 |
| High Tide Inc. (HITI)vs › | $237.69M | 0.81 | 0.81 | 0.76 | 0.71 |
| BioAge Labs Inc. (BIOA)vs › | $237.38M | 17.19 | 13.55 | 8.08 | 8.08 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | 1.54 | 1.17 | 19.33 | 29.22 |
| MacroGenics, Inc. (MGNX)vs › | $235.50M | 2.96 | 4.42 | 4.46 | 4.62 |
| Invivyd, Inc. (IVVD)vs › | $247.82M | 5.86 | 4.06 | 6.91 | 7.76 |
Quick Ratio
8.22
Excludes inventory
Current Ratio
8.22
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.22 |
| 2026-03-31 | 4.16 |
| 2025-12-31 | 4.13 |
| 2025-09-30 | 3.06 |
| 2025-06-30 | 3.78 |
| 2025-03-31 | 4.86 |
| 2024-12-31 | 4.57 |
| 2024-09-30 | 4.61 |
| 2024-06-30 | 7.97 |
| 2024-03-31 | 7.94 |
| 2023-12-31 | 5.82 |
| 2023-09-30 | 11.78 |
| 2023-06-30 | 14.95 |
| 2023-03-31 | 10.36 |
| 2022-12-31 | 7.48 |
| 2022-09-30 | 10.30 |
| 2022-06-30 | 9.03 |
| 2022-03-31 | 5.47 |
| 2021-12-31 | 5.10 |
| 2021-09-30 | 7.74 |
| 2021-06-30 | 13.04 |
| 2021-03-31 | 17.68 |
| 2020-12-31 | 8.54 |
| 2020-09-30 | 8.65 |
| 2020-06-30 | 8.12 |
| 2020-03-31 | 9.32 |
| 2019-12-31 | 8.46 |
| 2019-09-30 | 7.74 |
| 2019-06-30 | 10.49 |
| 2019-03-31 | 18.08 |
| 2018-12-31 | 20.39 |
| 2018-09-30 | 18.68 |
| 2018-06-30 | 43.98 |
| 2018-03-31 | 27.62 |
| 2017-12-31 | 25.90 |
| 2017-09-30 | 8.78 |
| 2017-06-30 | 9.99 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 16.81 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
